-transparent.png){kind=logo}
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway, by B.-Q. Wu, Y. Cao, Z.-G. Bi, published in Eur Rev Med Pharmacol Sci 2017; 21 (14): 3185-3192-PMID: 28770967" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/13139.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
B-Q Wu, and
Y Cao, and
Z-G Bi
September 2015,
Oncogenesis,
B-Q Wu, and
Y Cao, and
Z-G Bi
July 2014,
Molecular and cellular biochemistry,
B-Q Wu, and
Y Cao, and
Z-G Bi
October 2022,
Biomolecules,
B-Q Wu, and
Y Cao, and
Z-G Bi
December 2018,
Oncotarget,
B-Q Wu, and
Y Cao, and
Z-G Bi
October 2021,
Discover. Oncology,
B-Q Wu, and
Y Cao, and
Z-G Bi
December 2020,
Aging,
B-Q Wu, and
Y Cao, and
Z-G Bi
January 2021,
Journal of immunology research,
B-Q Wu, and
Y Cao, and
Z-G Bi
January 2020,
American journal of translational research,
B-Q Wu, and
Y Cao, and
Z-G Bi
January 2022,
Anti-cancer agents in medicinal chemistry,
B-Q Wu, and
Y Cao, and
Z-G Bi
January 2017,
International journal of ophthalmology,
